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Background:Malaria has become a threat to health in the tropi-
cal and other developing countries. Nowonder this has becomeone
of the components of the Millennium Development Goals (MDGs).
Malaria accounts for one in ﬁve of all childhood deaths in Africa. Yet
much of the impact of this disease on the world’s children could be
prevented with currently available interventions.
Methods & Materials: This study was carried out in Aba, Abia
State, Nigeria between themonths of July and October, 2012. Three
hundred patients were tested using thick ﬁlm method for the pres-
ence ofmalaria parasites. Apre-tested structural questionnairewas
used to obtain the demographic data and home management prac-
tices from parents of the children.
Results:Out of 300 children sampled, 195 (65.0%)were infected
withmalaria parasites. Ninety seven (62.2%) of those infectedwere
males, while 98 (68.1%) were females. However, the prevalence
rate of infection among the males and females were statistically
insigniﬁcant (P-value<0.05). Children of age ﬁve had the high-
est prevalence of 73.8%, followed by the children of age two with
prevalence rate of 68.0%. Children living in homes where preven-
tivemeasureswere adopted recorded lower rate of infection. Those
using insecticide treated nets (ITNs) had the lowest rate of infection
(23.1%). This is followedby those using combinedwindow/door net
plus insecticide sprays (45.5%), while the homes where no control
measures were adopted recorded 92.7% rate of infection.
Conclusion: The difference in prevalence rates among homes
using different control measures were statistically signiﬁcant (P-
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Background: American tegumentary leishmaniasis (ATL) is a
neglected disease of South America where metastatic mucosal
lesions (ML) can be seen in up to 5-20% of Leishmania Viannia
complex infections. The Leishmania RNA virus-1 (LRV1) has been
recently implicated as a possible pathogenic agent in ATL since
disseminated disease (DisL) was induced by high LRV1-expressing
amastigotes in an animal model, and human cases of DisL have
been reportedly infected with LRV1-containing Leishmania para-
sites. None of these studies clearly supported its role in human
disease.
Methods & Materials: Fifty-six subjects with parasitologically
conﬁrmedATLwereclinically andparasitologically assessed. Lesion
biopsy specimens were processed for detection and quantiﬁcation
of Leishmania (Viannia)DNA by a quantitative real-time PCR (qPCR)
assay targeting kinetoplast DNA (kDNA) minicircles. Leishmania
(Viannia) specieswere identiﬁed by PCR targeting thempi gene and
PCR-RFLP assays targeting cpb and hsp70 genes. LRV1 RNA detec-
tionwasperformedusing reverse transcription (RT)-qPCR targeting
conserved viral sequences.
Results: Subjects were clinically classiﬁed as follows: a) Local-
ized cutaneous leishmaniasis (LCL, 42.9%), b) ML (n=28, 50%), and
c) DisL (n =4, 7.1%). Strain identiﬁcation by clinical categorywas: a)
LCL: L. (V.) braziliensis (56%) and L. (V.) guyanensis (31.3%), b) ML: L.
(V.) braziliensis (60%) and L. (V.) peruviana (40%), and c) DisL: L. (V.)
guyanensis. Rateof LRV1detectionwas7.1% inML (2/28), 8.3% in LCL
(2/24) and 50% in DisL (2/4). Considering DisL and ML as metastatic
disease (MD) and LCL as non-metastatic disease (nMD), the rate
of LRV1 detection was 8.3% in nMD and 12,5% in MD (p=1.0).
Even though detection of LRV1 was higher in DisL, an important
co-morbidity was detected in those patients: HIV infection, subcli-
nical TB infection, anddisseminatedmycobacterialdisease. Parasite
load in MD and nMD was comparable (37.8 vs. 86.4 parasites per
106 human cells, p =0.52). There were no clinical or parasitological
differences between parasite infected and non-infected by LRV1.
Conclusion: Our ﬁndings do not resemble those reported in ani-
mal models. LRV1 may be a conditional contributor to metastatic
